Compressed tablet manufacture of Duzhong Shanzha Powder begins with mesh-size verification on vibratory sieves conforming to ISO 3310-1, because this bark-and-fruit botanical powder can retain a coarse fraction that produces specking in the finished dosage form. A 60-mesh passage of at least 95% w/w is generally required before the powder is charged into a 600 L bin blender for dry pre-mixing at 10–12 rpm for 20 min. Wet granulation is performed with an aqueous solution of povidone K30 at 2.5% w/w dry binder, using a top-spray fluidised bed processor with inlet air temperature between 60–65 °C and exhaust temperature held at 40–45 °C. Granulation endpoint is accepted only when loss-on-drying falls below 3.0% w/w, because higher residual moisture softens the granulate and increases sticking on high-speed rotary press tooling. The dried granulate is milled through a 1.2 mm screen, blended with croscarmellose sodium at 3.0% w/w and magnesium stearate at 0.5% w/w for not more than 2 min, and transferred directly to the press hopper. Compression is carried out on a 35-station rotary tablet press at 8–12 kN; target hardness is 70–100 N and friability is held below 1.0%. Disintegration is assessed in 900 mL of 0.1 M hydrochloric acid at 37 °C using the Chinese Veterinary Pharmacopoeia 2020 method; a rupture time above 30 min indicates overgranulation or excessive compression force. Bulk density of the granulate should remain between 0.45 g/mL and 0.60 g/mL to maintain consistent die filling. Content uniformity is checked on 10 units according to USP <905>. The final tablet core may contain Duzhong Shanzha Powder at 15–25% w/w, with filler and binder adjusted to the dose selected by the marketing authorisation holder; the active ratio is fixed by the finished product specification, not by the API vendor. This dosage form is intended for oral administration to swine, cattle, and companion animals where individual dosing is required.

What Limits Sterile Filtration of Decoction-Derived Duzhong Shanzha Solutions?

Aqueous extraction of Duzhong Shanzha Powder for injectable preparations requires a two-stage clarification train before the solution approaches the sterilising grade membrane. Decoction-derived material contains pectin-like polysaccharides from Crataegus and eucommiol glycosides from Eucommia bark; these fractions are not fully removed by centrifugation alone. The crude filtrate is therefore passed through a 0.45 µm depth filter followed by a 0.22 µm polyethersulfone sterilising filter, with upstream clarification monitored by filter pressure differential. In campaigns where the 0.45 µm stage is overloaded, the 0.22 µm membrane may blind after fewer than 500 L/m², although published data for this specific configuration is limited and the user should qualify throughput on a process-scale skid. Injectable solutions of Duzhong Shanzha Powder are compounded under cleanroom-grade conditions consistent with veterinary GMP, with the bulk solution held at 5–15 °C to minimise oxidative discolouration before sterile filtration. The formulation is adjusted to pH 5.5–6.5 with dilute hydrochloric acid or sodium hydroxide, and osmolality is corrected to 285–310 mOsm/kg with sodium chloride or dextrose. Endotoxin control is verified by bacterial endotoxin testing; if the water extract is prepared under non-sterile conditions, depyrogenation may be required before final aseptic filtration. Vials are filled under ISO 14644-1 Grade A conditions and terminally inspected for particulate matter. Final release includes sterility testing according to the Chinese Veterinary Pharmacopoeia 2020. The finished injectable product is intended for veterinary parenteral use only where the health authority has approved a sterile route; the raw powder itself is not sterile and must not be introduced directly into an injection.

In a gravity-fed capsule filler handling low-bulk-density Duzhong Shanzha Powder, the powder is first densified by roller compaction because the tapped bulk density of the native milled powder is frequently below 0.45 g/mL, a condition that causes plug sticking and erratic fill weight. Roller compaction at 4–6 kN/cm roll pressure produces flakes that are milled through a 0.8 mm screen and blended with croscarmellose sodium at 3–5% w/w. The densified granulate is filled into size 1 hard gelatin or HPMC capsules at target fill weights between 250 mg and 400 mg. Finished capsules are checked for moisture below 4.0% w/w and for dissolution using USP <711> Apparatus 2 at 50 rpm in 900 mL of water at 37 °C. Capsule-based delivery is used in companion animal dose units where a measured oral dose is more acceptable than a medicated premix. A final content uniformity test according to USP <905> on 10 units is applied to detect segregation of the low-density botanical fraction during the filling campaign. Because Duzhong Shanzha Powder may contain hygroscopic polysaccharides, the filling suite relative humidity is maintained below 60% RH, and bulk containers are closed within 30 min of dispensing to limit moisture uptake.

Dispersion and Sedimentation Control in Drinking Water Granules

Water-dispersible granules prepared from Duzhong Shanzha Powder are formulated with rapidly disintegrating carriers because the native powder contains lipophilic triterpenic acids from Crataegus that remain poorly wettable in cold hard water. A high-shear granulation step is used to embed the powder in a water-soluble matrix; a pilot formulation contains Duzhong Shanzha Powder at 10% w/w, lactose monohydrate at 68% w/w, citric acid at 12% w/w, sodium bicarbonate at 8% w/w, povidone K30 at 2% w/w, and sodium lauryl sulfate at 0.2% w/w. The granulate is dried to 2.5% w/w or lower moisture and sized through a 20-mesh screen to limit dust and improve flow. After dilution into drinking water at 1 g/L, the finished granule should wet within 10 s and leave no visible sediment after 30 min of agitation in hard water at 500 ppm calcium carbonate equivalent. Farm-line evaluation includes screening through a 60-mesh filter to detect coarse fragments that would block nipple drinkers. The terminal product is distributed as a water-soluble powder or granule for poultry, swine, or calves, and is not intended for continuous dosing unless specifically approved in the target species.

Premix Carrier Selection and Trace Mineral Interaction

In feed mill premixes, Duzhong Shanzha Powder is diluted with a carrier after evaluation of angle of repose, bulk density, and particle size distribution. The powder’s fine fraction below 100 µm tends to segregate in ribbon mixers unless the carrier bulk density is matched within 0.15 g/mL. Corncob meal at 40–60 mesh or ground rice husk is commonly selected; the botanical powder is combined in a double-ribbon mixer at 20 rpm for 15–20 min, with a coefficient of variation target below 5.0% for 20 sampling points. The presence of trace mineral premixes containing copper sulfate pentahydrate can accelerate oxidative polymerisation of polyphenols from Duzhong Shanzha Powder; coated trace minerals or separated addition of mineral premixes are therefore recommended in the master mix. A finished premix concentrate may contain Duzhong Shanzha Powder at 5% w/w, with light liquid paraffin as dust suppressant at 0.5% w/w. Batch-to-batch carryover is evaluated by cleaning the mixer with a rinsing charge of ground corn at 1.0% of mixer working capacity, and cross-contamination is controlled by sequencing such that the following premix is assayed by HPLC for marker polyphenols quantified against a validated reference standard. Premixes prepared under hygienic conditions must meet the microbial and heavy metal limits of the relevant national feed hygiene standard, with plate counts checked against the purchaser’s release specification. This dosage form is intended for further dilution in complete feed at the feed mill or on farm.

When Sorbitol Content Is High in Liquid Oral Duzhong Shanzha Dosage

Sugar-free oral solutions for calves and foals frequently replace sucrose with sorbitol at 20–30% w/v, which shifts the rheological profile of a 1:10 aqueous decoction of Duzhong Shanzha from Newtonian to slightly pseudoplastic. Preservation efficacy in such systems is assessed using USP <51> antimicrobial effectiveness testing; sodium benzoate at 0.1–0.2% w/v and potassium sorbate at 0.1% w/v provide adequate control only when the solution pH is maintained below 4.5. The clarified decoction is prepared by heating Duzhong Shanzha Powder in purified water at 85–90 °C for 60 min, followed by plate filtration and cooling to 20–25 °C before addition of the sweetener and preservatives. The terminal oral solution is filled into amber polyethylene terephthalate bottles to reduce photodegradation of polyphenolic pigments; clarity is checked after 30 days at 4 °C and 25 °C, with haze regarded as a failure of the filtration step rather than a preservative issue. Viscosity of the final solution is typically below 50 mPa·s at 25 °C when the sorbitol concentration does not exceed 30% w/v. This liquid dosage form is administered by drenching or dosing gun in ruminant and equine settings, and is not suitable for parenteral use.